These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23165285)

  • 1. TACI mutation p.Lys154Ter identified in Good Syndrome.
    Margraf RL; Coonrod EM; Durtschi JD; Augustine NH; Voelkerding KV; Hill HR; Kumánovics A
    Clin Immunol; 2013 Jan; 146(1):10-2. PubMed ID: 23165285
    [No Abstract]   [Full Text] [Related]  

  • 2. TACI mutation in Good's Syndrome: in search of a genetic basis.
    Sáenz-Cuesta M; Martínez-Pomar N; de Gracia J; Echaniz P; Villegas E; Prada A; Otaegui D; Matamoros N; Cuadrado E
    Clin Immunol; 2012 Oct; 145(1):27-30. PubMed ID: 22922270
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of the C104R TACI Mutation in Patients With Primary Antibody Deficiency.
    Lucena JM; Burillo Sanz S; Núñez-Roldan A; Sánchez B
    J Investig Allergol Clin Immunol; 2015; 25(5):378-9. PubMed ID: 26727773
    [No Abstract]   [Full Text] [Related]  

  • 4. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
    Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane Activator and Caml Interactor (Taci) Haploinsufficiency in B-Cell Dysfunction in a Patient with Smith-Magenis Syndrome.
    Karaca E; Atik T; Alpman Durmaz A; Ozkinay F; Cogulu O
    Genet Couns; 2016; 27(2):251-4. PubMed ID: 29485832
    [No Abstract]   [Full Text] [Related]  

  • 6. BAFF-R mutations in Good's syndrome.
    Lougaris V; Vitali M; Baronio M; Tampella G; Plebani A
    Clin Immunol; 2014 Jul; 153(1):91-3. PubMed ID: 24727458
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes.
    Pulvirenti F; Zuntini R; Milito C; Specchia F; Spadaro G; Danieli MG; Pession A; Quinti I; Ferrari S
    J Immunol Res; 2016; 2016():8390356. PubMed ID: 27123465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice.
    Jabara HH; Lee JJ; Janssen E; Ullas S; Liadaki K; Garibyan L; Benson H; Sannikova T; Bram R; Hammarstrom L; Cruz AC; Siegel R; Manis J; Malley R; Geha RS
    J Allergy Clin Immunol; 2017 Apr; 139(4):1293-1301.e4. PubMed ID: 27609654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three different faces of TACI mutations.
    Cekic S; Cicek F; Karali Y; Gorukmez O; Eren E; Kilic SS
    Scand J Immunol; 2020 Jun; 91(6):e12879. PubMed ID: 32160337
    [No Abstract]   [Full Text] [Related]  

  • 10. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
    Lee JJ; Ozcan E; Rauter I; Geha RS
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI.
    Grant JR; Moise AR; Jefferies WA
    Clin Vaccine Immunol; 2007 Jul; 14(7):907-17. PubMed ID: 17538121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) mutations associated with common variable immunodeficiency.
    Fried AJ; Rauter I; Dillon SR; Jabara HH; Geha RS
    J Allergy Clin Immunol; 2011 Jul; 128(1):226-228.e1. PubMed ID: 21419480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency.
    Castigli E; Wilson S; Garibyan L; Rachid R; Bonilla F; Schneider L; Morra M; Curran J; Geha R
    Nat Genet; 2007 Apr; 39(4):430-1. PubMed ID: 17392798
    [No Abstract]   [Full Text] [Related]  

  • 14. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID).
    Garibyan L; Lobito AA; Siegel RM; Call ME; Wucherpfennig KW; Geha RS
    J Clin Invest; 2007 Jun; 117(6):1550-7. PubMed ID: 17492055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary antibody deficiency syndromes.
    Wood PM
    Curr Opin Hematol; 2010 Jul; 17(4):356-61. PubMed ID: 20442656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor.
    Sathkumara HD; De Silva NR; Handunnetti S; De Silva AD
    Int J Immunogenet; 2015 Aug; 42(4):239-53. PubMed ID: 26096648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency.
    Pan-Hammarström Q; Salzer U; Du L; Björkander J; Cunningham-Rundles C; Nelson DL; Bacchelli C; Gaspar HB; Offer S; Behrens TW; Grimbacher B; Hammarström L
    Nat Genet; 2007 Apr; 39(4):429-30. PubMed ID: 17392797
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenotypic and clinical heterogeneity associated with monoallelic TNFRSF13B-A181E mutations in common variable immunodeficiency.
    Dong X; Hoeltzle MV; Hagan JB; Park MA; Li JT; Abraham RS
    Hum Immunol; 2010 May; 71(5):505-11. PubMed ID: 20156508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants.
    Hargreaves CE; Dhalla F; Patel AM; de Oteyza ACG; Bateman E; Miller J; Anzilotti C; Ayers L; Grimbacher B; Patel SY
    Clin Immunol; 2022 Jan; 234():108910. PubMed ID: 34922003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare mutations in TNFRSF13B increase the risk of asthma symptoms in Swedish children.
    Janzi M; Melén E; Kull I; Wickman M; Hammarström L
    Genes Immun; 2012 Jan; 13(1):59-65. PubMed ID: 21850030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.